Crystal structure, thermal behavior, and microbiological activity of a thiosemicarbazide-type ligand and its cobalt complexes

被引:14
作者
Hollo, Berta [1 ]
Rodic, Marko V. [1 ]
Vojinovic-Jesic, Ljiljana S. [1 ]
Zivkovic-Radovanovic, Vukosava [2 ]
Vuckovic, Gordana [2 ]
Leovac, Vukadin M. [1 ]
Szecsenyi, Katalin Meszaros [1 ]
机构
[1] Univ Novi Sad, Fac Sci, Novi Sad 21000, Serbia
[2] Univ Belgrade, Fac Chem, Belgrade 11158, Serbia
关键词
Co-III and mixed-valence Co-III/Co-II complex; 2-Acetylpyridine S-methylisothiosemicarbazone; TG/DSC; EGA-MS; Biological activity; TRANSITION-METAL-COMPLEXES; SPECTRAL CHARACTERIZATION; MASS-SPECTROMETRY; X-RAY; NI(II); CU(II); CO(II); ZN(II); IDENTIFICATION; EXCIPIENTS;
D O I
10.1007/s10973-013-3489-1
中图分类号
O414.1 [热力学];
学科分类号
070201 [理论物理];
摘要
The synthesis of a potentially bioactive mixed-valence Co-III/Co-II complex with 2-acetylpyridine S-methylisothiosemicarbazone (HL) ligand is described. The crystal and molecular structure of the formed [(CoL2)-L-III][(CoCl3)-Cl-II py]center dot Me2CO (I) compound (py stands for pyridine) is determined by single-crystal X-ray crystallography. It's thermal decomposition along with the decomposition of the ligand and six structurally related complexes with formulas [CoL2]NO3 center dot MeOH (1), [CoL2]Br center dot MeOH (2), [CoL2]HSO4 center dot MeOH (3), [CoL2](2)[Co-II(NCS)(4)] (4), [Co(HL)(L)]I-2 center dot 2MeOH (5), and [Co(HL)(L)][(CoCl4)-Cl-II]center dot MeOH (6) was determined by simultaneous TG/DSC measurements. The decomposition pattern is evaluated using TG/DTA-MS data. The results were related to the solvent/moisture content and the decomposition mechanism of the compounds. The antimicrobial activity of the ligand and of all the complexes was tested in vitro for selected gram-negative and gram-positive bacteria and fungi. The activity of the ligand against all tested bacteria is comparable with those obtained for standard antibiotics, while it is less active against fungi. Surprisingly, the activity of the complexes is very low. The low antimicrobial activity of the complexes may be in connection with their high thermodynamic and kinetic inertness in solution. The results are also supported by the relatively high thermal stability of the complexes.
引用
收藏
页码:655 / 662
页数:8
相关论文
共 44 条
[1]
TABLES OF BOND LENGTHS DETERMINED BY X-RAY AND NEUTRON-DIFFRACTION .1. BOND LENGTHS IN ORGANIC-COMPOUNDS [J].
ALLEN, FH ;
KENNARD, O ;
WATSON, DG ;
BRAMMER, L ;
ORPEN, AG ;
TAYLOR, R .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1987, (12) :S1-S19
[2]
COMPLETION AND REFINEMENT OF CRYSTAL-STRUCTURES WITH SIR92 [J].
ALTOMARE, A ;
CASCARANO, G ;
GIACOVAZZO, C ;
GUAGLIARDI, A .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 (pt 3) :343-350
[3]
Determination of minimum inhibitory concentrations [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :5-16
[4]
[Anonymous], CRYSALISPRO SOFTW SY
[5]
Synthesis, spectroscopic properties and biological evaluation of transition metal complexes of salicylhydrazone of anthranilhydrazide: X-ray crystal structure of copper complex [J].
Badiger, Dayananda S. ;
Hunoor, Rekha S. ;
Patil, Basavaraj R. ;
Vadavi, Ramesh S. ;
Mangannavar, Chandrashekhar V. ;
Muchchandi, Iranna S. ;
Patil, Yogesh P. ;
Nethaji, Munirathinam ;
Gudasi, Kalagouda B. .
INORGANICA CHIMICA ACTA, 2012, 384 :197-203
[6]
Bell S.M., 2013, Antibiotic susceptibility testing by the CDS method, V6th
[7]
Transition metal complexes with thiosemicarbazide-based ligands.: Part XLI.: Two crystal structures of cobalt(III) complexes with salicylaldehyde S-methylisothiosemicarbazone and theoretical study on orientations of coordinated pyridines [J].
Bogdanovic, GA ;
Medakovic, VB ;
Vojinovic, LS ;
Cesljevic, VI ;
Leovac, VM ;
Spasojevic-de Biré, A ;
Zaric, SD .
POLYHEDRON, 2001, 20 (17) :2231-2240
[8]
Crystal structure of tris(pyridine)(salicylaldehyde semicarbazonato(2-))cobalt(III)-trichloropyridinecobaltate(II) at 293 and 120 K [J].
Bogdanovic, Goran A. ;
Leovac, Vukadin M. ;
Vojinovic-Jesic, Ljiljana S. ;
Spasojevic-De Bire, Anne .
JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, 2007, 72 (01) :63-71
[9]
CDC, 2011, ANN REP 2011 PROGR I
[10]
Chaubey A., 2011, Asian J. Pharm. Clin. Res, V4, P5